Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Moderate Buy” by Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has earned a consensus rating of “Moderate Buy” from the fourteen analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $31.1538.

PRVA has been the subject of a number of analyst reports. Evercore set a $26.00 price target on Privia Health Group in a report on Wednesday, April 8th. Barclays decreased their price objective on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Zacks Research cut Privia Health Group from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 7th. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Finally, Canaccord Genuity Group reduced their target price on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 8th.

Insider Transactions at Privia Health Group

In related news, Director Matthew Shawn Morris sold 53,722 shares of the company’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $27.24, for a total transaction of $1,463,387.28. Following the transaction, the director owned 68,188 shares of the company’s stock, valued at approximately $1,857,441.12. This represents a 44.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 21,275 shares of the firm’s stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $27.67, for a total transaction of $588,679.25. Following the sale, the chief financial officer owned 164,853 shares in the company, valued at approximately $4,561,482.51. This trade represents a 11.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 452,357 shares of company stock worth $11,436,655 over the last ninety days. 5.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. ArrowMark Colorado Holdings LLC increased its stake in shares of Privia Health Group by 139.4% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company’s stock valued at $19,946,000 after acquiring an additional 489,866 shares during the last quarter. Freestone Grove Partners LP boosted its position in shares of Privia Health Group by 40.6% in the fourth quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after acquiring an additional 350,194 shares during the last quarter. Renaissance Group LLC acquired a new stake in shares of Privia Health Group in the fourth quarter worth approximately $7,776,000. Qube Research & Technologies Ltd grew its holdings in Privia Health Group by 93.3% in the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock valued at $14,013,000 after purchasing an additional 294,101 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in Privia Health Group in the second quarter valued at approximately $6,219,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $23.96 on Thursday. The business’s fifty day moving average price is $24.61 and its two-hundred day moving average price is $23.36. The stock has a market cap of $3.02 billion, a PE ratio of 149.76, a price-to-earnings-growth ratio of 1.88 and a beta of 0.85. Privia Health Group has a one year low of $19.08 and a one year high of $28.82.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.